~ Appreciates Adar Poonawalla Clean City Initiative
Pune, November 14, 2016: Hon’ble Prime Minister Shri Narendra Modi visited Serum Institute of India Pvt Ltd, one of the world’s largest vaccine manufacturers and appreciated all efforts undertaken as part of ‘Adar Poonawalla Clean City Initiative’ for Swachh Bharat Mission. Some of the other dignitaries who graced the occasion were Hon’ble Chief Minister of Maharashtra Shri Devendra Fadnavis, Former Agriculture Minister Shri Sharad Pawar, Hon’ble Union Human Resource Development Minister Prakash Jawadekar and Hon’ble Governor of Maharashtra Shri Vidyasagar Rao.
Mr Adar Poonawalla, CEO, Serum Institute of India, said, “We are honoured and priviledged to have hosted Hon’ble Prime Minister Shri Narendra Modi during his recent visit to our facility. The Hon’ble Prime Minister stressed that more companies should come forward to produce such vaccines so that poor children could be protected from diseases. We further briefed him on our Clean City Initiative. He was impressed and said that it was a good initiative under the Swachh Bharat Mission.”
With an investment of Rs.100 crore as CSR funding from Serum Institute of India and Mr. Adar Poonawalla, this initiative promotes idea of clean city. The initiative has been successfully implemented through scientifically collecting and removing garbage from city streets.
Serum Institute of India Pvt. Ltd. is the world's largest vaccine manufacturer in number of doses manufactured and supplied to more than 140 countries. The vaccines include Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps, Rubella, Meningitis A, Influenza and Polio vaccines. One of every two children born in the world receive a vaccine manufactured by Serum Institute. Serum Institute has established the most modern laboratories with high-tech machinery and computerized equipment for the production and testing of its life saving biologicals. Serum Institute's commitment to global health is exemplified by significant investments in its infrastructure. The production facilities are continuously upgraded to ensure compliance with cGMP regulations and have been accredited by the World Health Organization, Geneva.